A dramatic response to a single dose of infliximab in a patient with prolonged pustular psoriasis derived from inverse psoriasis.
We report a case of a 25-year-old Chinese man with an exceptionally prolonged history of pustular psoriasis derived from inverse psoriasis who was unsatisfied with conventional treatment and was successfully treated with a single dose of infliximab without noticeable adverse effects. No recurrence or flaring was observed after 3 months of follow-up. This case illustrates that infliximab may be an effective and safe therapeutic option for patients with refractory pustular psoriasis derived from inverse psoriasis.
['Li|Mengmeng|M|', 'Dai|Weiwei|W|', 'Yan|Wei|W|', 'Liu|Yuanzhen|Y|', 'Wang|Lian|L|', 'Li|Wei|W|http://orcid.org/0000-0002-9585-2884']
D000328:Adult D003879:Dermatologic Agents D006801:Humans D000069285:Infliximab D008297:Male D011565:Psoriasis
infliximab pustular psoriasis inverse psoriasis